Tolterodine Tartrate Patent Expiration
Tolterodine Tartrate was first introduced by Upjohn Us 2 Llc
Tolterodine Tartrate Patents
Given below is the list of patents protecting Tolterodine Tartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Detrol La |
US6630162 (Pediatric) | Pharmaceutical formulation and its use |
May 11, 2020
(Expired) | Upjohn |
| Detrol La |
US6911217 (Pediatric) | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
May 11, 2020
(Expired) | Upjohn |
| Detrol La |
US6770295 (Pediatric) | Therapeutic formulation for administering tolterodine with controlled release |
Feb 26, 2020
(Expired) | Upjohn |
| Detrol La | US6630162 | Pharmaceutical formulation and its use |
Nov 11, 2019
(Expired) | Upjohn |
| Detrol La | US6911217 | Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
Nov 11, 2019
(Expired) | Upjohn |
| Detrol La | US6770295 | Therapeutic formulation for administering tolterodine with controlled release |
Aug 26, 2019
(Expired) | Upjohn |
| Detrol |
US5382600 (Pediatric) | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep 25, 2012
(Expired) | Upjohn |
| Detrol La |
US5382600 (Pediatric) | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep 25, 2012
(Expired) | Upjohn |
Tolterodine Tartrate's Family Patents
Explore Our Curated Drug Screens
Tolterodine Tartrate Generic API Manufacturers
Several generic applications have been filed for Tolterodine Tartrate. The first generic version for Tolterodine Tartrate was by Apotex Corp and was approved on Sep 25, 2012. And the latest generic version is by Unichem Laboratories Ltd and was approved on Aug 27, 2024.
Given below is the list of companies who have filed for Tolterodine Tartrate generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | capsule, extended release | Prescription | ORAL | AB | May 19, 2020 |
| 2MG | capsule, extended release | Prescription | ORAL | AB | May 19, 2020 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. APOTEX CORP
Apotex Corp has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Apotex Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Discontinued | ORAL | N/A | Sep 25, 2012 |
| 1MG | tablet | Discontinued | ORAL | N/A | Sep 25, 2012 |
Manufacturing Plant Locations New
Apotex Corp's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Apotex Corp as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. AUROBINDO PHARMA USA
Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | capsule, extended release | Discontinued | ORAL | N/A | Oct 31, 2013 |
| 4MG | capsule, extended release | Discontinued | ORAL | N/A | Oct 31, 2013 |
Manufacturing Plant Locations New
Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. ELYSIUM
Elysium Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Elysium.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
| 2MG | tablet | Prescription | ORAL | AB | Dec 30, 2019 |
Manufacturing Plant Locations New
Elysium's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Elysium as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
5. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | capsule, extended release | Prescription | ORAL | AB | Dec 12, 2017 |
| 2MG | capsule, extended release | Prescription | ORAL | AB | Dec 12, 2017 |
6. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Aug 2, 2021 |
| 2MG | tablet | Prescription | ORAL | AB | Aug 2, 2021 |
7. INVENTIA HLTHCARE
Inventia Healthcare Private Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Inventia Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | capsule, extended release | Prescription | ORAL | AB | Aug 19, 2019 |
| 4MG | capsule, extended release | Prescription | ORAL | AB | Aug 19, 2019 |
8. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
| 1MG | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Aug 31, 2015 |
| 1MG | tablet | Prescription | ORAL | AB | Aug 31, 2015 |
10. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Discontinued | ORAL | N/A | Nov 27, 2012 |
| 2MG | tablet | Discontinued | ORAL | N/A | Nov 27, 2012 |
11. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | capsule, extended release | Prescription | ORAL | AB | Nov 22, 2016 |
| 2MG | capsule, extended release | Prescription | ORAL | AB | Nov 22, 2016 |
12. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | capsule, extended release | Prescription | ORAL | AB | Aug 11, 2015 |
| 4MG | capsule, extended release | Prescription | ORAL | AB | Aug 11, 2015 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
13. UNICHEM
Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Aug 5, 2020 |
| 2MG | capsule, extended release | Prescription | ORAL | AB | Aug 27, 2024 |
| 4MG | capsule, extended release | Prescription | ORAL | AB | Aug 27, 2024 |
Manufacturing Plant Locations New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||
| United States |
| |||||||||||||
14. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Unique.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Prescription | ORAL | AB | Jan 24, 2020 |
| 2MG | tablet | Prescription | ORAL | AB | Jan 24, 2020 |
Manufacturing Plant Locations New
Unique's manufacturing plants are situated in 5 countries - United States, India, Canada, Portugal, Taiwan. Given below are the details of these plant locations as well as the firm names of Unique as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||||
| Canada |
| |||||||||||||||||||||||||||||||
| Portugal |
| |||||||||||||||||||||||||||||||
| Taiwan |
| |||||||||||||||||||||||||||||||
15. UTOPIC PHARMS
Utopic Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tolterodine Tartrate. Given below are the details of the strengths of this generic introduced by Utopic Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | capsule, extended release | Prescription | ORAL | AB | Feb 2, 2021 |
| 2MG | capsule, extended release | Prescription | ORAL | AB | Feb 2, 2021 |